Clinical rationale for topical antimicrobial preparations

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 3, 1996, Pages 399-402

  Langford, Jane H ^a   Benrimoj, Shalom I ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; DILUTION CURVE; DRUG BIOAVAILABILITY; DRUG DESIGN; EDITORIAL; MINIMUM INHIBITORY CONCENTRATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS; CHEMISTRY, PHARMACEUTICAL; MICROBIAL SENSITIVITY TESTS;

EID: 0029979513     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.3.399     Document Type: Editorial

References (30)

1. Aly, R. (1985). Prophylactic efficacy of Bactroban and other topical antibiotics. Part 1: Antimicrobial action of Bactroban ointment applied to normal human skin. In Bactroban (Mupirocin) (Dobson, R. L., Leyden, J J., Noble, W. C. & Price, J. D., Eds), pp. 72-7. Excerpta Medica, Current Clinical Practice Series No. 16.
2. Aly, R. & Maibach, H. I (1981). In vivo methods for testing topical antimicrobial agents. Journal of the Society of Cosmetic Chemists 32, 317-23.
3. American Medical Association. (1983). Dermatologic preparations. In AMA Drug Evaluations, 5th edn, pp. 1339-97. American Medical Association, Chicago, IL.
4. Anderson, V (1976). Over-the-counter topical antibiotic products data on safety and efficacy. International Journal of Dermatology 15, Suppl., 1-118.
5. Berenbaum, M. C., Yu, V. L. & Felegie, T. P. (1983) Synergy with double and triple antibiotic combinations compared. Journal of Antimicrobial Chemotherapy 12, 555-63
6. Calandra, G. B., Norden, C., Nelson, J. D. & Mader, J. T. (1992). Evaluation of new anti-infective drugs for the treatment of selected infections of the skin and skin structure. Clinical Infectious Diseases 15, Suppl. 1, S148-54
7. Casewell, M. W & Hill, R. L. R. (1987) Mupirocin ('pseudomonic acid') - a promising new topical antimicrobial agent. Journal of Antimicrobial Chemotherapy 19, 1-5.
8. Eliopoulos, G. M. & Eliopoulos, C. T. (1988). Antibiotic combinations: should they be tested? Clinical Microbiology Review 1, 139-56.
9. Food and Drug Administration. (1982). Topical antimicrobial drug products for over-the-counter human use; tentative final monograph. Federal Register 47(132). 29986-30000. Department of Health and Human Services, Food and Drug Administration, Rockville, MD.
10. Hallander, H O., Dornbusch, K., Gezelius, L., Jacobson, K. & Karlsson, I. (1982). Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrobial Agents and Chemotherapy 22, 743-52.
11. Holm, S. (1986). Interaction between β-lactam and other antibiotics. Reviews in Infectious Diseases 8, Suppl. 3, S305-14.
12. Isenberg, H. D. (1988). Antimicrobial susceptibility testing: a critical evaluation. Journal of Antimicrobial Chemotherapy 22, Suppl A, 73-86.
13. King, T. C., Schlessinger, D. & Krogstad, D. J. (1981). The assessment of antimicrobial combinations. Reviews in Infectious Diseases 3, 627-33.
14. Lentner, C (1982). Geigy Scientific Tables. Introduction to Statistics, Statistical Tables, Mathematical Formulae, 8th edn. Vol. 2, pp. 89-102. Ciba-Geigy, Basle.
15. Leyden, J. J , Stewart, R. & Kligman, A. M. (1979). Updated in vivo methods for evaluating topical antimicrobial agents on human skin. Journal of Investigative Dermatology 72, 165-70.
16. Leyden, J. J. & Sulzberger, M. B. (1981). Topical antibiotics and minor skin trauma. American Family Physician 23, 121-5.
17. Lorian, V. (1980). Antibiotics in Laboratory Medicine Williams & Wilkins, Baltimore
18. Marples, R. R. & Kligman, A. M. (1974) Methods for evaluating topical antibacterial agents on human skin. Antimicrobial Agents and Chemotherapy 5, 323-9.
19. Mertz, P M , Alvarez, O M., Smerbeck, R. V. & Eaglstein, W. H. (1984), A new in vivo model for the evaluation of topical antiseptics on superficial wounds. Archites in Dermatology 120, 58-62.
20. Moellering, R. C. (1979). Antimicrobial synergism -an elusive concept. Journal of Infectious Diseases 140, 639-41.
21. National Committee for Clinical Laboratory Standards. (1985). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard M7-A. NCCLS, Villanova, PA.
22. Norden, C. W., Wentzel, H. & Keleti, E. (1979). Comparison of techniques for measurement of In vitro antibiotic synergism. Journal of Infectious Diseases 140, 629-33.
23. Parenti, M. A., Hatfield, S. M. & Leyden, J. J. (1987). Mupirocin: a topical antibiotic with a unique structure and mechanism of action. Clinical Pharmacy 6, 761-70.
24. Platt, J. & Bucknall, R A. (1984) An experimental evaluation of antiseptic wound irrigation. Journal of Hospital Infection 5, 181-8.
25. Reifenrath, W. G., Hawkins, G. S. & Kurtz, M. S. (1991) Percutaneous penetration and skin retention of topically applied, compounds: an in vitroin vivo study. Journal of Pharmaceutical Science 80, 526-32.
26. Report. (1991). Guidelines for good clinical research practice (GCRP) in Australia. DEB 3. Therapeutic Goods Administration, Commonwealth Department of Health, Housing and Community Services, Woden.
27. Sutherland, R., Boon, R. J., Griffin, K. E., Masters, P. J., Slocombe, B. & White, A. R. (1985). Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrobial Agents and Chemotherapy 27, 495-8.
28. Ward, A & Campoli-Richards, D M. (1986). Mupirocin a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 32, 425-44.
29. Williamson, P. & Kligman, A. M. (1965). A new method for the quantitative investigation of cutaneous bacteria. Journal of Investigative Dermatology 45, 498-503.
30. Working Party Report of the British Society for Antimicrobial Chemotherapy. The clinical evaluation of antibacterial drugs Journal of Antimicrobial Chemotherapy 23, Suppl. B.